Doxorubicin (Advectus)

N/A

Report date: 2026/01/26 13:50:18

Base Information

Drug NameDoxorubicin (Advectus)
Drug Alias NameDoxorubicinP80DOX-NP
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitorsVirus DNA polymerase inhibitors
TargetsVirus DNA polymeraseTopoisomerase II
Therapy Area/IndicationsBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdvectus Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvectus Life Sciences Inc
Active IndicationsN/A
Inactive IndicationsBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A